TWST - Twist Bioscience Corp
IEX Last Trade
47.9
0.440 0.919%
Share volume: 16,639
Last Updated: Fri 27 Dec 2024 08:30:24 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.25%
PREVIOUS CLOSE
CHG
CHG%
$47.46
0.44
0.93%
Fundamental analysis
8%
Profitability
0%
Dept financing
5%
Liquidity
75%
Performance
0%
Performance
5 Days
2.30%
1 Month
1.87%
3 Months
6.11%
6 Months
3.68%
1 Year
28.73%
2 Year
124.46%
Key data
Stock price
$47.90
DAY RANGE
$46.42 - $48.68
52 WEEK RANGE
$28.78 - $60.90
52 WEEK CHANGE
$33.55
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/15/2024
Company detail
CEO: Emily M. Leproust
Region: US
Website: twistbioscience.com
Employees: 990
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: twistbioscience.com
Employees: 990
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium.
Recent news